CN105566499A - 一种多聚体酶-抗体及其制备方法 - Google Patents
一种多聚体酶-抗体及其制备方法 Download PDFInfo
- Publication number
- CN105566499A CN105566499A CN201610013923.XA CN201610013923A CN105566499A CN 105566499 A CN105566499 A CN 105566499A CN 201610013923 A CN201610013923 A CN 201610013923A CN 105566499 A CN105566499 A CN 105566499A
- Authority
- CN
- China
- Prior art keywords
- enzyme
- polymer
- antibody
- solution
- mark
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920000642 polymer Polymers 0.000 title claims abstract description 81
- 238000002360 preparation method Methods 0.000 title abstract description 8
- 102000004190 Enzymes Human genes 0.000 claims abstract description 109
- 108090000790 Enzymes Proteins 0.000 claims abstract description 109
- 238000000034 method Methods 0.000 claims abstract description 38
- 238000001514 detection method Methods 0.000 claims abstract description 14
- 108060003951 Immunoglobulin Proteins 0.000 claims description 26
- 102000018358 immunoglobulin Human genes 0.000 claims description 26
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 24
- 108040007629 peroxidase activity proteins Proteins 0.000 claims description 24
- 230000003213 activating effect Effects 0.000 claims description 16
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 12
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 12
- 230000004913 activation Effects 0.000 claims description 9
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 7
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 7
- 241000283973 Oryctolagus cuniculus Species 0.000 claims description 7
- 241001494479 Pecora Species 0.000 claims description 7
- 108010046334 Urease Proteins 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 7
- 241000283707 Capra Species 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 6
- 238000013016 damping Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 238000003364 immunohistochemistry Methods 0.000 claims description 5
- SENLDUJVTGGYIH-UHFFFAOYSA-N n-(2-aminoethyl)-3-[[3-(2-aminoethylamino)-3-oxopropyl]-[2-[bis[3-(2-aminoethylamino)-3-oxopropyl]amino]ethyl]amino]propanamide Chemical class NCCNC(=O)CCN(CCC(=O)NCCN)CCN(CCC(=O)NCCN)CCC(=O)NCCN SENLDUJVTGGYIH-UHFFFAOYSA-N 0.000 claims description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims description 4
- DPDMMXDBJGCCQC-UHFFFAOYSA-N [Na].[Cl] Chemical compound [Na].[Cl] DPDMMXDBJGCCQC-UHFFFAOYSA-N 0.000 claims description 4
- 229940098773 bovine serum albumin Drugs 0.000 claims description 4
- 239000012634 fragment Substances 0.000 claims description 4
- 229940072221 immunoglobulins Drugs 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 239000001488 sodium phosphate Substances 0.000 claims description 4
- 229910000162 sodium phosphate Inorganic materials 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 claims description 4
- 230000003902 lesion Effects 0.000 claims description 3
- 241001529936 Murinae Species 0.000 claims description 2
- 102000013415 peroxidase activity proteins Human genes 0.000 claims 4
- 230000035945 sensitivity Effects 0.000 abstract description 11
- 238000002372 labelling Methods 0.000 abstract description 8
- 239000000969 carrier Substances 0.000 abstract 2
- 229920001503 Glucan Polymers 0.000 abstract 1
- 239000000412 dendrimer Substances 0.000 abstract 1
- 229920000736 dendritic polymer Polymers 0.000 abstract 1
- 238000006116 polymerization reaction Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 description 27
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 23
- 239000000243 solution Substances 0.000 description 23
- 102000003992 Peroxidases Human genes 0.000 description 20
- 239000003550 marker Substances 0.000 description 20
- 239000003153 chemical reaction reagent Substances 0.000 description 18
- 238000012151 immunohistochemical method Methods 0.000 description 14
- 229930003756 Vitamin B7 Natural products 0.000 description 13
- 239000011735 vitamin B7 Substances 0.000 description 13
- 235000011912 vitamin B7 Nutrition 0.000 description 13
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 102000016938 Catalase Human genes 0.000 description 6
- 108010053835 Catalase Proteins 0.000 description 6
- 239000000872 buffer Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 102000000905 Cadherin Human genes 0.000 description 4
- 108050007957 Cadherin Proteins 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000005516 engineering process Methods 0.000 description 4
- 229920000962 poly(amidoamine) Polymers 0.000 description 4
- 238000003375 selectivity assay Methods 0.000 description 4
- 238000010186 staining Methods 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000012447 hatching Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001575 pathological effect Effects 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 229920002307 Dextran Polymers 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 102000009875 Ki-67 Antigen Human genes 0.000 description 2
- 108010020437 Ki-67 Antigen Proteins 0.000 description 2
- 102000019040 Nuclear Antigens Human genes 0.000 description 2
- 108010051791 Nuclear Antigens Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 241000173347 Tonsilla Species 0.000 description 2
- 238000001261 affinity purification Methods 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000018044 dehydration Effects 0.000 description 2
- 238000006297 dehydration reaction Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000011532 immunohistochemical staining Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 210000002741 palatine tonsil Anatomy 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000012797 qualification Methods 0.000 description 2
- 230000001173 tumoral effect Effects 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000006395 Globulins Human genes 0.000 description 1
- 108010044091 Globulins Proteins 0.000 description 1
- 108010039918 Polylysine Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 201000008275 breast carcinoma Diseases 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 150000001875 compounds Chemical group 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002055 immunohistochemical effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002203 pretreatment Methods 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000012747 synergistic agent Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
- C07K16/4208—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
- C07K16/4241—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0065—Oxidoreductases (1.) acting on hydrogen peroxide as acceptor (1.11)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/03—Phosphoric monoester hydrolases (3.1.3)
- C12Y301/03001—Alkaline phosphatase (3.1.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
- C12Y305/01005—Urease (3.5.1.5)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/535—Production of labelled immunochemicals with enzyme label or co-enzymes, co-factors, enzyme inhibitors or enzyme substrates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/54—F(ab')2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- General Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610013923.XA CN105566499B (zh) | 2016-01-06 | 2016-01-06 | 一种多聚体酶‑抗体及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610013923.XA CN105566499B (zh) | 2016-01-06 | 2016-01-06 | 一种多聚体酶‑抗体及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105566499A true CN105566499A (zh) | 2016-05-11 |
CN105566499B CN105566499B (zh) | 2017-06-16 |
Family
ID=55877179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610013923.XA Active CN105566499B (zh) | 2016-01-06 | 2016-01-06 | 一种多聚体酶‑抗体及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105566499B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110632324A (zh) * | 2019-09-25 | 2019-12-31 | 百盛(广州)生物制品有限公司 | 用于二抗检测系统的聚酰胺胺结构多聚物及其制备方法 |
CN110665486A (zh) * | 2019-10-17 | 2020-01-10 | 福州大学 | 一种磁性四氧化三铁-pamam-抗体复合体及其制备方法和应用 |
CN111551709A (zh) * | 2020-05-13 | 2020-08-18 | 河南赛诺特生物技术有限公司 | 一种酶标二抗复合物及其制备方法 |
CN112305222A (zh) * | 2020-11-05 | 2021-02-02 | 东莞市医本生物科技有限公司 | 一种小多聚体酶-抗体片段及其制备与应用 |
CN112661850A (zh) * | 2020-12-02 | 2021-04-16 | 杭州百凌生物科技有限公司 | 一种多抗组合物及其制备方法和在病理检测的应用 |
CN112834736A (zh) * | 2020-12-02 | 2021-05-25 | 杭州百凌生物科技有限公司 | 一种检测多种抗原的病理检测试剂盒及其制备方法和应用 |
CN114113605A (zh) * | 2021-11-04 | 2022-03-01 | 贵州美鑫达医疗科技有限公司 | 用于脑瘤术中快速免疫组化的多聚酶-抗体组合 |
US20220229062A1 (en) * | 2021-01-21 | 2022-07-21 | Diagnostic Biosystems | Method for rapid immunohistochemical detection of an antigen from a biological sample |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311856A (zh) * | 1998-07-30 | 2001-09-05 | 安德克斯有限公司 | 制备水溶性交联轭合物的方法 |
CN1580774A (zh) * | 2004-05-14 | 2005-02-16 | 沈阳迈迪生物医学技术有限公司 | 乳腺癌的Her-2免疫组织化学诊断试剂盒 |
-
2016
- 2016-01-06 CN CN201610013923.XA patent/CN105566499B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1311856A (zh) * | 1998-07-30 | 2001-09-05 | 安德克斯有限公司 | 制备水溶性交联轭合物的方法 |
CN1580774A (zh) * | 2004-05-14 | 2005-02-16 | 沈阳迈迪生物医学技术有限公司 | 乳腺癌的Her-2免疫组织化学诊断试剂盒 |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110632324A (zh) * | 2019-09-25 | 2019-12-31 | 百盛(广州)生物制品有限公司 | 用于二抗检测系统的聚酰胺胺结构多聚物及其制备方法 |
CN110665486A (zh) * | 2019-10-17 | 2020-01-10 | 福州大学 | 一种磁性四氧化三铁-pamam-抗体复合体及其制备方法和应用 |
CN110665486B (zh) * | 2019-10-17 | 2021-05-18 | 福州大学 | 一种磁性四氧化三铁-pamam-抗体复合体及其制备方法和应用 |
CN111551709A (zh) * | 2020-05-13 | 2020-08-18 | 河南赛诺特生物技术有限公司 | 一种酶标二抗复合物及其制备方法 |
CN111551709B (zh) * | 2020-05-13 | 2021-04-02 | 河南赛诺特生物技术有限公司 | 一种酶标二抗复合物及其制备方法 |
CN112305222A (zh) * | 2020-11-05 | 2021-02-02 | 东莞市医本生物科技有限公司 | 一种小多聚体酶-抗体片段及其制备与应用 |
CN112661850A (zh) * | 2020-12-02 | 2021-04-16 | 杭州百凌生物科技有限公司 | 一种多抗组合物及其制备方法和在病理检测的应用 |
CN112834736A (zh) * | 2020-12-02 | 2021-05-25 | 杭州百凌生物科技有限公司 | 一种检测多种抗原的病理检测试剂盒及其制备方法和应用 |
US20220229062A1 (en) * | 2021-01-21 | 2022-07-21 | Diagnostic Biosystems | Method for rapid immunohistochemical detection of an antigen from a biological sample |
CN114113605A (zh) * | 2021-11-04 | 2022-03-01 | 贵州美鑫达医疗科技有限公司 | 用于脑瘤术中快速免疫组化的多聚酶-抗体组合 |
Also Published As
Publication number | Publication date |
---|---|
CN105566499B (zh) | 2017-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105566499A (zh) | 一种多聚体酶-抗体及其制备方法 | |
Buchwalow et al. | Immunohistochemistry: basics and methods | |
CN103808926B (zh) | 纳米模拟酶免疫层析检测方法 | |
Sanderson et al. | 19—Immunohistochemical and immunofluorescent techniques | |
Ramos-Vara et al. | When tissue antigens and antibodies get along: revisiting the technical aspects of immunohistochemistry—the red, brown, and blue technique | |
CN104634974B (zh) | 肝内胆管癌的检出、辨别方法 | |
Mason et al. | Alkaline phosphatase and peroxidase for double immunoenzymatic labelling of cellular constituents. | |
Ramos-Vara | Technical aspects of immunohistochemistry | |
Jackson et al. | Immunohistochemical techniques | |
CN105785005A (zh) | 一种循环肿瘤细胞的检测试剂盒及其应用 | |
MXPA01010995A (es) | Un anticuerpo monoclonal contra la leucina aminopeptidasa estimulada por estrogenos. | |
Renshaw | Immunohistochemistry and immunocytochemistry | |
CN111006928B (zh) | 一种应用于免疫组织化学的封闭液及其使用方法 | |
CN103196731A (zh) | 用于鉴别乳腺肌上皮病变的多重染色试剂及其检测方法 | |
CN105334325A (zh) | 基于生物素和链霉亲和素系统的微流控免疫芯片分析方法 | |
CN107202895A (zh) | 一种基于适配体识别的凝血酶快速检测试纸条 | |
EP2664921B1 (en) | Assay | |
Bosman et al. | Clinical applications of the enzyme labeled antibody method. Immunoperoxidase methods in diagnostic histopathology. | |
US20200400674A1 (en) | A method of detecting magea4 | |
JPH05508078A (ja) | キチンを検出する分析装置及び方法 | |
US20060160151A1 (en) | Method of quantitative immunohistochemistry and in situ hybridization | |
Krenacs et al. | Multiple antigen immunostaining procedures | |
Hayat | Factors affecting antigen retrieval | |
CN102782497A (zh) | 测定 | |
Hasic | Immunohistochemistry Fundamentals |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190225 Address after: 361000 Floor 3 and 4 of Building B10, Xiamen Biomedical Industrial Park, 2068 Wengjiao West Road, Haicang District, Xiamen City, Fujian Province Patentee after: XIAMEN TALENT BIOMEDICAL TECHNOLOGY Co.,Ltd. Address before: 511458 Nansha District Huanshi City, Guangzhou City, Guangdong Province, to reach the fourth floor of Building C, District B, Nan8 Science and Technology Innovation Center Patentee before: ASCEND BIOTECHNOLOGY Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 361000 Floor 3 and 4 of Building B10, Xiamen Biomedical Industrial Park, 2068 Wengjiao West Road, Haicang District, Xiamen City, Fujian Province Patentee after: Xiamen Tongling Biomedical Technology Co.,Ltd. Country or region after: China Address before: 361000 Floor 3 and 4 of Building B10, Xiamen Biomedical Industrial Park, 2068 Wengjiao West Road, Haicang District, Xiamen City, Fujian Province Patentee before: XIAMEN TALENT BIOMEDICAL TECHNOLOGY Co.,Ltd. Country or region before: China |